Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003493176 | SCV004237652 | uncertain significance | Myopathy, centronuclear, 5 | 2023-06-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004673900 | SCV005172092 | uncertain significance | Inborn genetic diseases | 2024-05-24 | criteria provided, single submitter | clinical testing | The c.6415C>G (p.R2139G) alteration is located in exon 30 (coding exon 30) of the SPEG gene. This alteration results from a C to G substitution at nucleotide position 6415, causing the arginine (R) at amino acid position 2139 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |